Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001533228-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
39,000
Total Value
$807,829.10
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 1, 2026 | Exercise/Conversion | 13,000 | $15.47 | $201,110.00 | 13,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 13,000 | $46.67 | $606,719.10 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Oct 1, 2026 | Exercise/Conversion | 13,000 | $0.00 | $0.00 | 46,372 | Direct | โ | View Details |